← Evidence map

ArticleClinicoEconomics and outcomes research : CEOR2026

Pharmaceutical Manufacturing in China Innovation Performance: A Dynamic QCA Analysis Based on the WSR Perspective.

Wangwang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41926529